Cancer Genetics, Inc. Announces Proposed Public Offering of Common Stock
09 janv. 2019 16h00 HE
|
Cancer Genetics, Inc.
RUTHERFORD, N.J., Jan. 09, 2019 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology and genomic medicine through molecular markers...
Cancer Genetics Strengthens Management Team with Appointment of William Finger as Executive Vice President, Precision Medicine and Pharma Services
09 janv. 2019 08h00 HE
|
Cancer Genetics, Inc.
RUTHERFORD, N.J. and RESEARCH TRIANGLE PARK, N.C., Jan. 09, 2019 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology and genomics...
Cancer Genetics Terminates Proposed Merger with NovellusDx
17 déc. 2018 08h00 HE
|
Cancer Genetics, Inc.
RUTHERFORD, N.J., Dec. 17, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology and genomic medicine through molecular markers...
Cancer Genetics Reports Third Quarter 2018 Financial Results and Provides Strategic Business Updates
19 nov. 2018 16h16 HE
|
Cancer Genetics, Inc.
RUTHERFORD, N.J., Nov. 19, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology and genomic medicine through molecular markers...
Cancer Genetics Appoints Glenn Miles as Chief Financial Officer
14 nov. 2018 16h01 HE
|
Cancer Genetics, Inc.
RUTHERFORD, N.J., Nov. 14, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology and genomics through molecular markers and...
Cancer Genetics Enters Strategic Partnership with Genecast Biotechnology to Commercialize Tissue of Origin® Test in China
18 oct. 2018 09h05 HE
|
Cancer Genetics, Inc.
RUTHERFORD, N.J., Oct. 18, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology and genomics through molecular markers and...
Cancer Genetics Issues Letter to Shareholders
16 oct. 2018 08h00 HE
|
Cancer Genetics, Inc.
RUTHERFORD, N.J., Oct. 16, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology and genomics through molecular markers and...
Cancer Genetics and Cellaria Partner on Precision Medicine Tools
08 oct. 2018 07h00 HE
|
Cancer Genetics, Inc.
RUTHERFORD, N.J., Oct. 08, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology and genomics through molecular markers and...
Cancer Genetics Enters Supply Agreement with Agilent Technologies
25 sept. 2018 16h01 HE
|
Cancer Genetics, Inc.
RUTHERFORD, N.J., Sept. 25, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology and genomics through molecular markers and...
Cancer Genetics Offers Oncomine Comprehensive Assay to Drive Clinical Trials
20 sept. 2018 08h30 HE
|
Cancer Genetics, Inc.
RUTHERFORD, N.J., Sept. 20, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology and genomics through molecular markers and...